Free Access
| Issue |
Med Sci (Paris)
Volume 33, Number 6-7, Juin-Juillet 2017
|
|
|---|---|---|
| Page(s) | 582 - 585 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20173306008 | |
| Published online | 19 July 2017 | |
- Rossi A, Salvetti A. Intégration des vecteurs AAV et mutagenèse insertionnelle. Med Sci (Paris) 2016 ; 32 : 167–174. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Eichholz K, Bru T, Tran T, et al. Immune-complexed adenovirus induce AIM2-mediated pyroptosis in human dendritic cell. PLoS Pathog 2016 ; 12 : e1005871. [CrossRef] [PubMed] [Google Scholar]
- Miao E, Leaf I, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010 ; 11 : 1136–1142. [CrossRef] [PubMed] [Google Scholar]
- Henault J, Martinez J, Riggs JM, et al. Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes. Immunity 2012 ; 37 : 986–997. [CrossRef] [PubMed] [Google Scholar]
- Wiethoff CM, Wodrich H, Gerace L, Nemerow GR. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 2005 ; 79 : 1992–2000. [CrossRef] [PubMed] [Google Scholar]
- Barlan U, Griffin TM, McGuire KA, Wiethoff CM. Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol 2011 ; 85 : 146–155. [CrossRef] [PubMed] [Google Scholar]
- Jamilloux Y, Henry T. Les inflammasomes : Plates-formes de l’immunité innée. Med Sci (Paris) 2013 ; 29 : 975–984. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 2015 ; 526 : 660–665. [CrossRef] [PubMed] [Google Scholar]
- Doitsh G, Galloway NK, Geng X, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014 ; 505 : 509–514. [CrossRef] [PubMed] [Google Scholar]
- Mennechet FJ, Tran TT, Eichholz K, et al. Ebola virus vaccine: benefit and risks of adenovirus-based vectors. Expert Rev Vaccines 2015 ; 14 : 1–8. [CrossRef] [PubMed] [Google Scholar]
- Gray GE, Moodie Z, Metch B, et al. Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study. Lancet Infect Dis 2014 ; 14 : 388–396. [CrossRef] [PubMed] [Google Scholar]
- Duerr A, Huang Y, Buchbinder S, et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis 2012 ; 206 : 258–266. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.